Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
Tóm tắt
Từ khóa
Tài liệu tham khảo
Montinari, 2019, The first 3500years of aspirin history from its roots - A concise summary, Vasc.Pharmacol., 113, 1, 10.1016/j.vph.2018.10.008
Tsutsumi, 2004, Endoplasmic reticulum stress response is involved in nonsteroidal anti-inflammatory drug-induced apoptosis, Cell Death Differ., 11, 1009, 10.1038/sj.cdd.4401436
Gupta, 2016, NSAIDs in the Treatment of Postoperative Pain, Curr. Pain Headache Rep., 20, 62, 10.1007/s11916-016-0591-7
Budoff, 1979, Use of mefenamic acid in the treatment of primary dysmenorrhea, JAMA, 241, 2713, 10.1001/jama.1979.03290510021018
R.W.U. Daniel E. Furst, Shraddha Prakash Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Nonopioid Analgesics, & Drugs Used in Gout, in: B.G. Katzung (Ed.), Basic & Clinical Pharmacology, The McGraw-Hill Companies, Inc.2012, pp. 635-657.
E.M.S. Tilo Grosser, and Garret A. FitzGerald, Pharmacotherapy of Inflammation, Fever, Pain, and Gout, in: L.L. Brunton (Ed.), GOODMAN & GILMAN'S THE PHARMACOLOGICAL BASIS OF THERAPEUTICS, McGraw-Hill Education2018, pp. 685-709.
Ong, 2007, An evidence-based update on nonsteroidal anti-inflammatory drugs, Clin. Med. Res., 5, 19, 10.3121/cmr.2007.698
Dhalla, 2012, Opioids versus nonsteroidal anti-inflammatory drugs in noncancer pain, Can. Fam. Physician, 58, 30
Daniels, 2016, Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models, Nat. Commun., 7, 12504, 10.1038/ncomms12504
Wichmann, 2016, NSAID Use and Incident Cognitive Impairment in a Population-based Cohort, Alzheimer Dis. Assoc. Disord., 30, 105, 10.1097/WAD.0000000000000098
Breitner, 2009, Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort, Neurology, 72, 1899, 10.1212/WNL.0b013e3181a18691
Rao, 1995, Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent, Cancer Res., 55, 1464
Amici, 2006, Indomethacin has a potent antiviral activity against SARS coronavirus, Antivir Ther, 11, 1021, 10.1177/135965350601100803
James, 1999, The multisystem adverse effects of NSAID therapy, J. Am. Osteopath. Assoc., 99, S1, 10.7556/jaoa.1999.99.11.S1
Hooper, 1988, Monte Carlo simulations of laser-generated sea surface aureole, Appl. Opt., 27, 5111, 10.1364/AO.27.005111
Arfe, 2016, Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study, BMJ, 354
Dreischulte, 2015, Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury, Kidney Int., 88, 396, 10.1038/ki.2015.101
Becker, 2004, Current approaches to prevent NSAID-induced gastropathy–COX selectivity and beyond, Br. J. Clin. Pharmacol., 58, 587, 10.1111/j.1365-2125.2004.02198.x
Bjarnason, 2018, Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs, Gastroenterology, 154, 500, 10.1053/j.gastro.2017.10.049
Wallace, 2005, Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense, Br. J. Pharmacol., 145, 275, 10.1038/sj.bjp.0706201
Darling, 2004, The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice, Gastroenterology, 127, 94, 10.1053/j.gastro.2004.04.003
Bombardier, 2000, Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis, N. Engl. J. Med., 343, 1520, 10.1056/NEJM200011233432103
Matsui, 2011, The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine, J Clin Biochem Nutr, 48, 107, 10.3164/jcbn.10-79
Murray, 1993, Renal toxicity of the nonsteroidal anti-inflammatory drugs, Annu. Rev. Pharmacol. Toxicol., 33, 435, 10.1146/annurev.pa.33.040193.002251
Boelsterli, 2003, Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity, Toxicol. Appl. Pharmacol., 192, 307, 10.1016/S0041-008X(03)00368-5
Kowalski, 2015, Seven steps to the diagnosis of NSAIDs hypersensitivity: how to apply a new classification in real practice?, Allergy Asthma Immunol Res, 7, 312, 10.4168/aair.2015.7.4.312
J.O.B.F.J.R.A. Chicoine, Non‐steroidal Anti‐inflammatory Drugs in: J.F.K.J.D.M.J. Wang (Ed.), Chemical Analysis of Non‐antimicrobial Veterinary Drug Residues in Food, Wiley Online Library2016, pp. 427-496.
Warner, 1999, Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis, Proc Natl Acad Sci U S A, 96, 7563, 10.1073/pnas.96.13.7563
Tacconelli, 2017, Nonsteroidal anti-inflammatory drugs and cardiovascular safety - translating pharmacological data into clinical readouts, Expert Opin Drug Saf, 16, 791, 10.1080/14740338.2017.1338272
Rao, 2008, Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond, J. Pharm. Pharm. Sci., 11, 81s, 10.18433/J3T886
Wong, 2019, Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion, Adv. Pharmacol. Sci., 2019, 3418975
Conaghan, 2012, A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity, Rheumatol. Int., 32, 1491, 10.1007/s00296-011-2263-6
Lees, 2004, Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest, J. Vet. Pharmacol. Ther., 27, 479, 10.1111/j.1365-2885.2004.00617.x
Wyatt, 2012, Pharmacogenetics of nonsteroidal anti-inflammatory drugs, Pharmacogenomics J., 12, 462, 10.1038/tpj.2012.40
Crofford, 2013, Use of NSAIDs in treating patients with arthritis, Arthritis Res. Ther., 15, S2, 10.1186/ar4174
Mazaleuskaya, 2015, PharmGKB summary: ibuprofen pathways, Pharmacogenet. Genom., 25, 96, 10.1097/FPC.0000000000000113
Daly, 2007, Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes, Gastroenterology, 132, 272, 10.1053/j.gastro.2006.11.023
Jemnitz, 2010, ABCC2/Abcc2: a multispecific transporter with dominant excretory functions, Drug Metab. Rev., 42, 402, 10.3109/03602530903491741
Jedlitschky, 2006, Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition, Expert Opin. Drug Metab. Toxicol., 2, 351, 10.1517/17425255.2.3.351
Meunier, 2018, Recent Advances in Hepatotoxicity of Non Steroidal Anti-Inflammatory Drugs, Ann. Hepatol., 17, 187, 10.5604/01.3001.0010.8633
Kuehl, 2005, Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes, Drug Metab. Dispos., 33, 1027, 10.1124/dmd.104.002527
Wong, 2019, Disease-Modifying Effects of Long-Term and Continuous Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Spondyloarthritis, Adv Pharmacol Sci, 2019, 5324170
Cooper, 2019, Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say?, Drugs Aging, 36, 15, 10.1007/s40266-019-00660-1
J. Marjoribanks M. Proctor C. Farquhar R.S. Derks Nonsteroidal anti-inflammatory drugs for dysmenorrhoea Cochrane Database Syst Rev (1) 2010 CD001751.
Lundberg, 2018, Analgesic and anti-inflammatory drugs in sports: Implications for exercise performance and training adaptations, Scand. J. Med. Sci. Sports, 28, 2252, 10.1111/sms.13275
Steckling, 2020, Diclofenac attenuates inflammation through TLR4 pathway and improves exercise performance after exhaustive swimming, Scand. J. Med. Sci. Sports, 30, 264, 10.1111/sms.13579
Gorski, 2011, Use of NSAIDs in triathletes: prevalence, level of awareness and reasons for use, Br. J. Sports Med., 45, 85, 10.1136/bjsm.2009.062166
Walker, 2017, Widespread Use of Prescription Nonsteroidal Anti-Inflammatory Drugs Among U.S. Army Active Duty Soldiers, Mil. Med., 182, e1709, 10.7205/MILMED-D-16-00183
Pantziarka, 2016, Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent, Ecancermedicalscience, 10, 610
Zhang, 2018, Advances in antitumor effects of NSAIDs, Cancer Manag. Res., 10, 4631, 10.2147/CMAR.S175212
Thun, 2002, Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues, J. Natl. Cancer Inst., 94, 252, 10.1093/jnci/94.4.252
Ricchi, 2003, Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy, Br. J. Cancer, 88, 803, 10.1038/sj.bjc.6600829
Pallu, 2012, Anti-inflammatory Drugs for Cancer Prevention and Treatment: Emerging Options, J. Cancer Sci. Ther., 4, 10.4172/1948-5956.1000e117
Hilovska, 2015, Potency of non-steroidal anti-inflammatory drugs in chemotherapy, Mol. Clin. Oncol., 3, 3, 10.3892/mco.2014.446
Ma, 2015, Mechanistic Role of MicroRNA in Cancer Chemoprevention by Nonsteroidal Anti-inflammatory Drugs, Curr. Pharmacol Rep., 1, 154, 10.1007/s40495-014-0011-9
Izzotti, 2017, Early and late effects of aspirin and naproxen on microRNAs in the lung and blood of mice, either unexposed or exposed to cigarette smoke, Oncotarget, 8, 85716, 10.18632/oncotarget.20464
Li, 2013, Modeling of non-steroidal anti-inflammatory drug effect within signaling pathways and miRNA-regulation pathways, PLoS ONE, 8
Ishida, 2016, Repurposing of approved cardiovascular drugs, J. Transl. Med., 14, 269, 10.1186/s12967-016-1031-5
M.C. Zatelli, A. Luchin, F. Tagliati, S. Leoni, D. Piccin, M. Bondanelli, R. Rossi, E.C. degli Uberti, Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression, Endocr Relat Cancer 14(4) (2007) 1029-38.
Huang, 2017, Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E2 and down-regulating the Wnt pathway activity, Oncotarget, 8, 115254, 10.18632/oncotarget.23250
Blobaum, 2007, Structural and functional basis of cyclooxygenase inhibition, J. Med. Chem., 50, 1425, 10.1021/jm0613166
Coyle, 2016, ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours, Contemp. Clin Trials, 51, 56, 10.1016/j.cct.2016.10.004
Joharatnam-Hogan, 2019, Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial, Lancet Gastroenterol. Hepatol., 4, 854, 10.1016/S2468-1253(19)30289-4
Tsoi, 2019, Long-term use of low-dose aspirin for cancer prevention: A 10-year population cohort study in Hong Kong, Int. J. Cancer, 145, 267, 10.1002/ijc.32083
Magee, 2019, Nonsteroidal anti-inflammatory drugs and pain in cancer patients: a systematic review and reappraisal of the evidence, Br. J. Anaesth., 123, e412, 10.1016/j.bja.2019.02.028
Shebl, 2014, Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP study, PLoS ONE, 9, 10.1371/journal.pone.0114633
Hendrix, 2016, Repurposing the Nonsteroidal Anti-inflammatory Drug Diflunisal as an Osteoprotective, Antivirulence Therapy for Staphylococcus aureus Osteomyelitis, Antimicrob. Agents Chemother., 60, 5322, 10.1128/AAC.00834-16
Lago, 2019, Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis, EBioMedicine, 43, 370, 10.1016/j.ebiom.2019.04.029
Ogundeji, 2016, Repurposing of Aspirin and Ibuprofen as Candidate Anti-Cryptococcus Drugs, Antimicrob. Agents Chemother., 60, 4799, 10.1128/AAC.02810-15
Gold, 2012, Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials, Proc Natl Acad Sci U S A, 109, 16004, 10.1073/pnas.1214188109
Chittepu, 2019, Repurposing of FDA-Approved NSAIDs for DPP-4 Inhibition as an Alternative for Diabetes Mellitus Treatment: Computational and in Vitro Study, Pharmaceutics, 11, 10.3390/pharmaceutics11050238
Rawat, 2019, Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management, J. Neuroinflammation, 16, 197, 10.1186/s12974-019-1592-3
Joo, 2006, Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models, Mol. Pharmacol., 69, 76, 10.1124/mol.105.015206
Wongrakpanich, 2018, A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly, Aging Dis., 9, 143, 10.14336/AD.2017.0306
Thal, 2005, A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment, Neuropsychopharmacology, 30, 1204, 10.1038/sj.npp.1300690
Cunningham, 2012, Non-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium?, J. Neuroimmune Pharmacol., 7, 60, 10.1007/s11481-011-9312-5
Zhao-Fleming, 2018, Effect of non-steroidal anti-inflammatory drugs on post-surgical complications against the backdrop of the opioid crisis, Burns Trauma, 6, 25, 10.1186/s41038-018-0128-x
Griggs, 2017, Sedation and Pain Management in Burn Patients, Clin. Plast. Surg., 44, 535, 10.1016/j.cps.2017.02.026
Zarghi, 2011, Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships, Iran J. Pharm. Res., 10, 655
Vane, 1971, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs, Nat. New. Biol., 231, 232, 10.1038/newbio231232a0
Warner, 2002, Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?, Proc. Natl. Acad. Sci. U S A, 99, 13371, 10.1073/pnas.222543099
Vane, 2000, The fight against rheumatism: from willow bark to COX-1 sparing drugs, J. Physiol. Pharmacol., 51, 573
Varga, 2017, Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drugs: An Under-Recognized Public Health Issue, Cureus, 9
Simmons, 1989, Identification of a phorbol ester-repressible v-src-inducible gene, Proc. Natl. Acad. Sci. U S A, 86, 1178, 10.1073/pnas.86.4.1178
Xie, 1991, Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing, Proc. Natl. Acad. Sci. U S A, 88, 2692, 10.1073/pnas.88.7.2692
Chandrasekharan, 2002, COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression, Proc. Natl. Acad. Sci. U S A, 99, 13926, 10.1073/pnas.162468699
Jozwiak-Bebenista, 2014, Paracetamol: mechanism of action, applications and safety concern, Acta Pol. Pharm., 71, 11
Vane, 1998, Cyclooxygenases 1 and 2, Annu. Rev. Pharmacol. Toxicol., 38, 97, 10.1146/annurev.pharmtox.38.1.97
Vane, 1996, Introduction: mechanism of action of NSAIDs, Br. J. Rheumatol., 35, 1, 10.1093/rheumatology/35.suppl_1.1
Ghosh, 2015, NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species, Oxid. Med. Cell. Longev., 2015, 10.1155/2015/536962
M.W. King, Lipids: The Eicosanoids: Prostaglandins, Leukotrienes, and Thromboxanes, Integrative medical biochemistry : examination and board review, New York : McGraw-Hill Education/Medical2014.
Gierse, 1996, A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors, J. Biol. Chem., 271, 15810, 10.1074/jbc.271.26.15810
Rouzer, 2009, Cyclooxygenases: structural and functional insights, J. Lipid Res., 50, S29, 10.1194/jlr.R800042-JLR200
Kirkby, 2013, LC-MS/MS confirms that COX-1 drives vascular prostacyclin whilst gene expression pattern reveals non-vascular sites of COX-2 expression, PLoS ONE, 8, 10.1371/journal.pone.0069524
Mitchell, 2019, Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system, Br. J. Pharmacol., 176, 1038, 10.1111/bph.14167
Allaj, 2013, Non-steroid anti-inflammatory drugs, prostaglandins, and cancer, Cell Biosci, 3, 8, 10.1186/2045-3701-3-8
Breyer, 2001, Prostanoid receptors: subtypes and signaling, Annu. Rev. Pharmacol. Toxicol., 41, 661, 10.1146/annurev.pharmtox.41.1.661
Harizi, 2013, The immunobiology of prostanoid receptor signaling in connecting innate and adaptive immunity, Biomed Res. Int., 2013, 10.1155/2013/683405
Sandoval-Acuna, 2012, Inhibition of mitochondrial complex I by various non-steroidal anti-inflammatory drugs and its protection by quercetin via a coenzyme Q-like action, Chem. Biol. Interact., 199, 18, 10.1016/j.cbi.2012.05.006
Murphy, 2009, How mitochondria produce reactive oxygen species, Biochem. J., 417, 1, 10.1042/BJ20081386
Mazumder, 2016, Selective scavenging of intra-mitochondrial superoxide corrects diclofenac-induced mitochondrial dysfunction and gastric injury: A novel gastroprotective mechanism independent of gastric acid suppression, Biochem. Pharmacol., 121, 33, 10.1016/j.bcp.2016.09.027
Mazumder, 2019, Indomethacin impairs mitochondrial dynamics by activating the PKCzeta-p38-DRP1 pathway and inducing apoptosis in gastric cancer and normal mucosal cells, J. Biol. Chem., 294, 8238, 10.1074/jbc.RA118.004415
Braun, 2012, Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand, J, Invest. Dermatol., 132, 429, 10.1038/jid.2011.316
Farrugia, 2013, The proapoptotic effect of traditional and novel nonsteroidal anti-inflammatory drugs in mammalian and yeast cells, Oxid Med Cell Longev, 2013, 10.1155/2013/504230
Rayburn, 2009, Anti-Inflammatory Agents for Cancer Therapy, Mol Cell Pharmacol, 1, 29, 10.4255/mcpharmacol.09.05
Rosas, 2014, Celecoxib decreases growth and angiogenesis and promotes apoptosis in a tumor cell line resistant to chemotherapy, Biol. Res., 47, 27, 10.1186/0717-6287-47-27
Tsujimoto, 2018, The prevalence of endoscopic gastric mucosal damage in patients with rheumatoid arthritis, PLoS ONE, 13, 10.1371/journal.pone.0200023
Hamid, 2006, Frequency of NSAID induced peptic ulcer disease, J. Pak. Med. Assoc., 56, 218
Chatterjee, 2015, Cross-Sectional Study for Prevalence of Non-Steroidal Anti-Inflammatory Drug-Induced Gastrointestinal Cardiac and Renal Complications in India: Interim Report, Gastroenterology Res, 8, 216, 10.14740/gr658w
Dubois, 2004, Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy, Aliment. Pharmacol. Ther., 19, 197, 10.1111/j.0269-2813.2004.01834.x
Fine, 2013, Quantifying the impact of NSAID-associated adverse events, Am. J. Manag. Care, 19, s267
Sinha, 2013, Current perspectives in NSAID-induced gastropathy, Mediators Inflamm., 2013, 10.1155/2013/258209
Bhala, 2013, Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials, Lancet, 382, 769, 10.1016/S0140-6736(13)60900-9
Salvo, 2014, Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studies, Expert. Opin. Drug. Saf., 13, 573, 10.1517/14740338.2014.907792
Pirlamarla, 2016, FDA labeling of NSAIDs: Review of nonsteroidal anti-inflammatory drugs in cardiovascular disease, Trends Cardiovasc. Med., 26, 675, 10.1016/j.tcm.2016.04.011
Somasundaram, 1997, Mitochondrial damage: a possible mechanism of the “topical” phase of NSAID induced injury to the rat intestine, Gut, 41, 344, 10.1136/gut.41.3.344
Somasundaram, 2002, 2, 4-diamino-6- hydroxy pyrimidine inhibits NSAIDs induced nitrosyl-complex EPR signals and ulcer in rat jejunum, BMC Gastroenterol., 2, 8, 10.1186/1471-230X-2-8
Maity, 2009, Indomethacin, a non-steroidal anti-inflammatory drug, develops gastropathy by inducing reactive oxygen species-mediated mitochondrial pathology and associated apoptosis in gastric mucosa: a novel role of mitochondrial aconitase oxidation, J. Biol. Chem., 284, 3058, 10.1074/jbc.M805329200
Maity, 2009, Melatonin reduces indomethacin-induced gastric mucosal cell apoptosis by preventing mitochondrial oxidative stress and the activation of mitochondrial pathway of apoptosis, J. Pineal Res., 46, 314, 10.1111/j.1600-079X.2009.00663.x
Pal, 2010, Gallic acid prevents nonsteroidal anti-inflammatory drug-induced gastropathy in rat by blocking oxidative stress and apoptosis, Free Radic. Biol. Med., 49, 258, 10.1016/j.freeradbiomed.2010.04.013
Chattopadhyay, 2006, Indomethacin inactivates gastric peroxidase to induce reactive-oxygen-mediated gastric mucosal injury and curcumin protects it by preventing peroxidase inactivation and scavenging reactive oxygen, Free Radic. Biol. Med., 40, 1397, 10.1016/j.freeradbiomed.2005.12.016
Biswas, 2003, A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical, J. Biol. Chem., 278, 10993, 10.1074/jbc.M210328200
Bandyopadhyay, 2002, Gastroprotective effect of Neem (Azadirachta indica) bark extract: possible involvement of H(+)-K(+)-ATPase inhibition and scavenging of hydroxyl radical, Life Sci., 71, 2845, 10.1016/S0024-3205(02)02143-4
Chattopadhyay, 2004, Mechanism of antiulcer effect of Neem (Azadirachta indica) leaf extract: effect on H+-K+-ATPase, oxidative damage and apoptosis, Inflammopharmacology, 12, 153, 10.1163/1568560041352257
Fu, 2018, Gastroprotective and anti-ulcer effects of oxymatrine against several gastric ulcer models in rats: Possible roles of antioxidant, antiinflammatory, and prosurvival mechanisms, Phytother. Res., 32, 2047, 10.1002/ptr.6148
Hegab, 2018, Sadek, The gastroprotective effect of N-acetylcysteine and genistein in indomethacin-induced gastric injury in rats, Can. J. Physiol. Pharmacol., 96, 1161, 10.1139/cjpp-2017-0730
Ko, 2020, Evaluating the mucoprotective effect of polydeoxyribonucleotide against indomethacin-induced gastropathy via the MAPK/NF-kappaB signaling pathway in rats, Eur. J. Pharmacol., 874, 10.1016/j.ejphar.2020.172952
Bindu, 2013, Nonsteroidal anti-inflammatory drug induces proinflammatory damage in gastric mucosa through NF-kappaB activation and neutrophil infiltration: anti-inflammatory role of heme oxygenase-1 against nonsteroidal anti-inflammatory drug, Free Radic. Biol. Med., 65, 456, 10.1016/j.freeradbiomed.2013.07.027
Lohmander, 2005, A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis, Ann. Rheum. Dis., 64, 449, 10.1136/ard.2004.023572
Pai, 2001, Nonsteroidal anti-inflammatory drugs inhibit re-epithelialization of wounded gastric monolayers by interfering with actin Src, FAK, and tensin signaling, Life Sci., 69, 3055, 10.1016/S0024-3205(01)01412-6
Nadatani, 2019, Gastric acid inhibitor aggravates indomethacin-induced small intestinal injury via reducing Lactobacillus johnsonii, Sci. Rep., 9, 17490, 10.1038/s41598-019-53559-7
Sostres, 2013, Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage, Arthritis Res. Ther., 15, S3, 10.1186/ar4175
Shin, 2017, Non-steroidal anti-inflammatory drug-induced enteropathy, Intest. Res., 15, 446, 10.5217/ir.2017.15.4.446
Maiden, 2005, A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy, Gastroenterology, 128, 1172, 10.1053/j.gastro.2005.03.020
Graham, 2005, Visible small-intestinal mucosal injury in chronic NSAID users, Clin. Gastroenterol Hepatol., 3, 55, 10.1016/S1542-3565(04)00603-2
Watanabe, 2019, Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive review, J. Gastroenterol.
Nadatani, 2012, High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4, Am. J. Pathol., 181, 98, 10.1016/j.ajpath.2012.03.039
Jacob, 2007, Role of bile in pathogenesis of indomethacin-induced enteropathy, Arch. Toxicol., 81, 291, 10.1007/s00204-006-0149-2
Satoh, 2009, Role of dietary fibres, intestinal hypermotility and leukotrienes in the pathogenesis of NSAID-induced small intestinal ulcers in cats, Gut, 58, 1590, 10.1136/gut.2008.156596
Shimada, 2019, Involvement of gliadin, a component of wheat gluten, in increased intestinal permeability leading to non-steroidal anti-inflammatory drug-induced small-intestinal damage, PLoS ONE, 14, 10.1371/journal.pone.0211436
Laine, 2008, Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac, Gastroenterology, 135, 1517, 10.1053/j.gastro.2008.07.067
Whitfield-Cargile, 2017, The non-invasive exfoliated transcriptome (exfoliome) reflects the tissue-level transcriptome in a mouse model of NSAID enteropathy, Sci. Rep., 7, 14687, 10.1038/s41598-017-13999-5
Endo, 2011, Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study, J. Gastroenterol., 46, 894, 10.1007/s00535-011-0410-1
Suzuki, 2017, Yogurt Containing Lactobacillus gasseri Mitigates Aspirin-Induced Small Bowel Injuries: A Prospective Randomized, Double-Blind, Placebo-Controlled Trial, Digestion, 95, 49, 10.1159/000452361
B. Mortensen C. Murphy J. O'Grady M. Lucey G. Elsafi L. Barry V. Westphal A. Wellejus O. Lukjancenko A.C. Eklund H.B. Nielsen A. Baker A. Damholt J.E.T. van Hylckama Vlieg F. Shanahan M. Buckley Bifidobacteriumbreve Bif195 Protects Against Small-Intestinal Damage Caused by Acetylsalicylic Acid in Healthy Volunteers Gastroenterology 157 3 2019 pp. 637–646 e4.
Benjamin, 2019, Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association, Circulation, 139, e56, 10.1161/CIR.0000000000000659
Grosser, 2010, Emotion recollected in tranquility: lessons learned from the COX-2 saga, Annu. Rev. Med., 61, 17, 10.1146/annurev-med-011209-153129
Grosser, 2006, Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities, J. Clin. Invest., 116, 4, 10.1172/JCI27291
Nissen, 2016, Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis, N. Engl. J. Med., 375, 2519, 10.1056/NEJMoa1611593
FitzGerald, 2017, Imprecision: Limitations to Interpretation of a Large Randomized Clinical Trial, Circulation, 135, 113, 10.1161/CIRCULATIONAHA.116.026324
Garcia Rodriguez, 2008, Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population, J. Am. Coll. Cardiol., 52, 1628, 10.1016/j.jacc.2008.08.041
Moore, 2020, Coronary Risks Associated with Diclofenac and Other NSAIDs: An Update, Drug Saf., 43, 301, 10.1007/s40264-019-00900-8
F. Marsico, S. Paolillo, P.P. Filardi, NSAIDs and cardiovascular risk, J Cardiovasc Med (Hagerstown) 18 Suppl 1: Special Issue on The State of the Art for the Practicing Cardiologist: The 2016 Conoscere E Curare Il Cuore (CCC) Proceedings from the CLI Foundation (2017) e40-e43.
Miner, 2007, The discovery of aspirin's antithrombotic effects, Tex. Heart Inst. J., 34, 179
Belton, 2000, Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis, Circulation, 102, 840, 10.1161/01.CIR.102.8.840
Behrouz, 2015, Aspirin and intracerebral hemorrhage: Where are we now?, Neurol. Clin. Pract., 5, 11, 10.1212/CPJ.0000000000000089
Rapa, 2019, Inflammation and Oxidative Stress in Chronic Kidney Disease-Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites, Int. J. Mol. Sci., 21, 10.3390/ijms21010263
Bak, 2003, Risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nested case-control study, Stroke, 34, 379, 10.1161/01.STR.0000053029.45352.A0
Gelbenegger, 2019, Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups, BMC Med., 17, 198, 10.1186/s12916-019-1428-0
Ravach, 2020, Aspirin for primary cardiovascular prevention : the end of an era ?, Rev. Med. Suisse, 16, 459
Fosslien, 2005, Cardiovascular complications of non-steroidal anti-inflammatory drugs, Ann. Clin. Lab. Sci., 35, 347
Ahmetaj-Shala, 2015, Reply to letter regarding article, “evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs”, Circulation, 132, e213, 10.1161/CIRCULATIONAHA.115.017260
Ricciotti, 2018, Cyclooxygenase-2, Asymmetric Dimethylarginine, and the Cardiovascular Hazard From Nonsteroidal Anti-Inflammatory Drugs, Circulation, 138, 2367, 10.1161/CIRCULATIONAHA.118.033540
Yu, 2012, Vascular COX-2 modulates blood pressure and thrombosis in mice, Sci Transl Med 4(132), 132ra54
Ghosh, 2016, Diclofenac induces proteasome and mitochondrial dysfunction in murine cardiomyocytes and hearts, Int. J. Cardiol., 223, 923, 10.1016/j.ijcard.2016.08.233
Oh, 2018, Microarray analysis of NSAIDs-treated cardiomyocytes to search for genes involved in COX-2 inhibitor cardiotoxicity, Genet. Mol. Res., 17, GMR18068, 10.4238/gmr18068
Lucas, 2019, Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs, J. Bras. Nefrol., 41, 124, 10.1590/2175-8239-jbn-2018-0107
Y. Ziya Sener, M. Oksul, Effects of NSAIDs on kidney functions and cardiovascular system, J Clin Hypertens (Greenwich) 22(2) (2020) 302.
Bensman, 2019, Non-steroidal Anti-inflammatory Drugs (NSAIDs) Systemic Use: The Risk of Renal Failure, Front. Pediatr., 7, 517, 10.3389/fped.2019.00517
Ejaz, 2004, NSAIDs and kidney, J. Assoc. Physicians India, 52, 632
Rahman, 2014, Nonsteroidal antiinflammatory drugs, cyclooxygenase-2, and the kidneys, Prim. Care, 41, 803, 10.1016/j.pop.2014.09.001
Dixit, 2010, Significant Acute Kidney Injury Due to Non-steroidal Anti-inflammatory Drugs: Inpatient Setting, Pharmaceuticals (Basel), 3, 1279, 10.3390/ph3041279
Clave, 2019, The Invisible Threat of Non-steroidal Anti-inflammatory Drugs for Kidneys, Front. Pediatr., 7, 520, 10.3389/fped.2019.00520
Burukoglu, 2016, Effects of nonsteroidal anti-inflammatory meloxicam on stomach, kidney, and liver of rats, Toxicol. Ind. Health, 32, 980, 10.1177/0748233714538484
MacIntyre, 1986, Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators, Agents Actions Suppl., 20, 45
Lapi, 2013, Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study, BMJ, 346, 10.1136/bmj.e8525
Correction to: Cyclooxygenase-2 Selectively Controls Renal Blood Flow Through a Novel PPARbeta/delta-Dependent Vasodilator Pathway, Hypertension 71(3) (2018) e10.
Sowers, 2005, The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus, Arch. Intern. Med., 165, 161, 10.1001/archinte.165.2.161
Lefebvre, 2020, Non-steroidal anti-inflammatory drugs in chronic kidney disease: a systematic review of prescription practices and use in primary care, Clin Kidney J, 13, 63, 10.1093/ckj/sfz054
Ratliff, 2016, Oxidant Mechanisms in Renal Injury and Disease, Antioxid. Redox Signal., 25, 119, 10.1089/ars.2016.6665
Basivireddy, 2004, Indomethacin-induced renal damage: role of oxygen free radicals, Biochem. Pharmacol., 67, 587, 10.1016/j.bcp.2003.09.023
Fattori, 2017, Vinpocetine reduces diclofenac-induced acute kidney injury through inhibition of oxidative stress, apoptosis, cytokine production, and NF-kappaB activation in mice, Pharmacol. Res., 120, 10, 10.1016/j.phrs.2016.12.039
Prado, 2019, Prospective Monitoring of Drug Use: Drug-Induced Liver Injury in a Primary Healthcare Center, Arq. Gastroenterol., 56, 390, 10.1590/s0004-2803.201900000-73
Nonsteroidal Antiinflammatory Drugs (NSAIDs), (2012).
Bessone, 2010, Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?, World J. Gastroenterol., 16, 5651, 10.3748/wjg.v16.i45.5651
Sriuttha, 2018, Hepatotoxicity of Nonsteroidal Anti-Inflammatory Drugs: A Systematic Review of Randomized Controlled Trials, Int J Hepatol, 2018, 5253623, 10.1155/2018/5253623
O'Connor, 2003, Hepatocellular damage from non-steroidal anti-inflammatory drugs, QJM, 96, 787, 10.1093/qjmed/hcg138
Zoubek, 2020, Systematic review: ibuprofen-induced liver injury, Aliment. Pharmacol. Ther., 51, 603, 10.1111/apt.15645
Bessone, 2016, Hepatotoxicity induced by coxibs: how concerned should we be?, Expert Opin Drug Saf, 15, 1463, 10.1080/14740338.2016.1225719
Kwon, 2019, Nimesulide-induced hepatotoxicity: A systematic review and meta-analysis, PLoS ONE, 14, 10.1371/journal.pone.0209264
Masubuchi, 2000, Possible mechanism of hepatocyte injury induced by diphenylamine and its structurally related nonsteroidal anti-inflammatory drugs, J. Pharmacol. Exp. Ther., 292, 982
Bort, 1999, Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity, J. Pharmacol. Exp. Ther., 288, 65
Masubuchi, 2002, Role of mitochondrial permeability transition in diclofenac-induced hepatocyte injury in rats, Hepatology, 35, 544, 10.1053/jhep.2002.31871
Doi, 2010, Salicylic acid-induced hepatotoxicity triggered by oxidative stress, Chem. Biol. Interact., 183, 363, 10.1016/j.cbi.2009.11.024
Bolder, 1999, Sulindac is excreted into bile by a canalicular bile salt pump and undergoes a cholehepatic circulation in rats, Gastroenterology, 117, 962, 10.1016/S0016-5085(99)70356-2
Ahmad, 2018, Evaluation of naproxen-induced oxidative stress, hepatotoxicity and in-vivo genotoxicity in male Wistar rats, J. Pharm. Anal., 8, 400, 10.1016/j.jpha.2018.04.002
Souto, 2001, Kupffer cell-derived cyclooxygenase-2 regulates hepatocyte Bcl-2 expression in choledocho-venous fistula rats, Am. J. Physiol. Gastrointest. Liver Physiol., 280, G805, 10.1152/ajpgi.2001.280.5.G805
Rymer, 2011, Hemorrhagic stroke: intracerebral hemorrhage, Mo. Med., 108, 50
Park, 2014, Risk of stroke associated with nonsteroidal anti-inflammatory drugs, Vasc Health Risk Manag, 10, 25
T. Schink, B. Kollhorst, C. Varas Lorenzo, A. Arfe, R. Herings, S. Lucchi, S. Romio, R. Schade, M.J. Schuemie, H. Straatman, V. Valkhoff, M. Villa, M. Sturkenboom, E. Garbe, Risk of ischemic stroke and the use of individual non-steroidal anti-inflammatory drugs: A multi-country European database study within the SOS Project, PLoS One 13(9) (2018) e0203362.
Choi, 2008, Nonaspirin nonsteroidal anti-inflammatory drugs and hemorrhagic stroke risk: the Acute Brain Bleeding Analysis study, Stroke, 39, 845, 10.1161/STROKEAHA.107.497040
Islam, 2018, Risk of Hemorrhagic Stroke in Patients Exposed to Nonsteroidal Anti-Inflammatory Drugs: A Meta-Analysis of Observational Studies, Neuroepidemiology, 51, 166, 10.1159/000490741
L. Ge, X. Ouyang, C. Ban, H. Yu, Q. Wu, H. Wu, J. Liang, Cerebral microbleeds in patients with ischemic cerebrovascular disease taking aspirin or clopidogrel, Medicine (Baltimore) 98(9) (2019) e14685.
Li, 2019, Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and, Management, Med Sci (Basel), 7
White, 2018, Aspirin-Exacerbated Respiratory Disease, N. Engl. J. Med., 379, 1060, 10.1056/NEJMra1712125
White, 2018, Role of group 2 innate lymphocytes in aspirin-exacerbated respiratory disease pathogenesis, Am J Rhinol Allergy, 32, 7, 10.2500/ajra.2018.32.4498
Voiriot, 2019, Risks Related to the Use of Non-Steroidal Anti-Inflammatory Drugs in Community-Acquired Pneumonia in Adult and Pediatric Patients, J Clin Med, 8, 10.3390/jcm8060786
Wen, 2017, Acute Respiratory Infection and Use of Nonsteroidal Anti-Inflammatory Drugs on Risk of Acute Myocardial Infarction: A Nationwide Case-Crossover Study, J. Infect. Dis., 215, 503, 10.1093/infdis/jiw603
Dauletbaev, 2010, Ibuprofen modulates NF-kB activity but not IL-8 production in cystic fibrosis respiratory epithelial cells, Respiration, 79, 234, 10.1159/000255342
Lewandowska-Polak, 2019, Parainfluenza virus infection enhances NSAIDs-induced inhibition of PGE2 generation and COX-2 expression in human airway epithelial cells, Adv. Med. Sci., 64, 338, 10.1016/j.advms.2019.04.004
Yan, 2006, Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein, Int. J. Biochem. Cell Biol., 38, 1417, 10.1016/j.biocel.2006.02.003
Russell, 2020, COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?, Ecancermedicalscience, 14, 1023, 10.3332/ecancer.2020.1023
Jaya PreethiPeesa, 2016, Arun Rasheed, Venkata Basaveswara Rao Mandava, A perspective review on role of novel NSAID prodrugs in the management of acute inflammation, J. Acute Dis., 5, 364, 10.1016/j.joad.2016.08.002
T.J.A. Maureen Younan Jeffrey, Fudin, A Practical Approach to Discontinuing NSAID Therapy Prior to a Procedure (Accessed 10 2013 13).
Qandil, 2012, Prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review, Int. J. Mol. Sci., 13, 17244, 10.3390/ijms131217244
Mahmud, 1996, Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation, Arthritis Rheum., 39, 1998, 10.1002/art.1780391208
Makhija, 2013, Synthesis and pharmacological evaluation of antiinflammatory mutual amide prodrugs, Indian J Pharm Sci, 75, 353, 10.4103/0250-474X.117399
Rao, 2010, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development, Pharmaceuticals (Basel), 3, 1530, 10.3390/ph3051530
Fiorucci, 2011, Hydrogen sulfide-based therapies: focus on H2S releasing NSAIDs, Inflamm. Allergy Drug Targets, 10, 133, 10.2174/187152811794776213
Wallace, 2019, Nitric oxide in the gastrointestinal tract: opportunities for drug development, Br. J. Pharmacol., 176, 147, 10.1111/bph.14527
Fiorucci, 2007, NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon, Dig Liver Dis, 39, 1043, 10.1016/j.dld.2007.09.001
Wallace, 2018, Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic, Antioxid. Redox Signal., 28, 1533, 10.1089/ars.2017.7068
Wallace, 2020, A proof-of-concept, Phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide-releasing anti-inflammatory drug, Br. J. Pharmacol., 177, 769, 10.1111/bph.14641
Zheng, 2015, Hydrogen sulfide prodrugs-a review, Acta Pharm Sin B, 5, 367, 10.1016/j.apsb.2015.06.004
Pan, 2017, The Role of Hydrogen Sulfide on Cardiovascular Homeostasis: An Overview with Update on Immunomodulation, Front. Pharmacol., 8, 686, 10.3389/fphar.2017.00686
Lobb, 2015, Hydrogen sulphide and the kidney: important roles in renal physiology and pathogenesis and treatment of kidney injury and disease, Nitric Oxide, 46, 55, 10.1016/j.niox.2014.10.004